Rapid eye movement sleep induction by vasoactive intestinal peptide infused into the oral pontine tegmentum of the rat may involve muscarinic receptors

Neuroscience

Volumn 89, Issue 1, 1999, Pages 291-302

  Bourgin, P ^a   Ahnaou, A ^a   Laporte, A M ^a   Hamon, M ^a   Adrien, J ^a  

^a INSERM   (France)

Author keywords

Autoradiography; Muscarinic receptors; Nucleus reticularis pontis oralis; Sleep waking cycle; Vasoactive intestinal peptide

Indexed keywords

ATROPINE; CARBACHOL; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; PIRENZEPINE; QUINUCLIDINYL BENZILATE; SODIUM CHLORIDE; TRITIUM; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PONS RETICULAR FORMATION; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP WAKING CYCLE; TEGMENTUM;

ANIMALS; ATROPINE; AUTORADIOGRAPHY; BRAIN CHEMISTRY; CARBACHOL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROINJECTIONS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; PIRENZEPINE; PONS; QUINUCLIDINYL BENZILATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; SLEEP, REM; TRITIUM; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033105910     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00290-5     Document Type: Article

References (75)

1. Agoston D. V., Borroni E. and Richardson P. J. (1988) Cholinergic surface antigen chol-1 is present in a subclass of VIP-containing rat cortical synaptosomes. J. Neurochem. 50, 1659-1662.
2. Akiba I., Kubo T., Maeda A., Bujo H., Nakai J., Mishina M. and Numa S. (1988) Primary structure of porcine mAChR III and antagonist binding studies. Fedn Eur. Biochem. Socs Lett. 235, 257-261.
3. Baccari M. C., Calamai F. and Staderini G. (1994) Modulation of cholinergic transmission by nitric oxide, VIP and ATP in the gastric muscle. Neuroreport 5, 905-908.
4. Baghdoyan H. A. (1997) Location and quantification of muscarinic receptor subtypes in rat pons: Implications for REM sleep generation. Am. J. Physiol. 273, R896-R904.
5. Belvisi M. G., Miura M., Stretton D. and Barnes P. J. (1993) Endogenous vasoactive intestinal peptide and nitric oxide modulate cholinergic neurotransmission in guinea-pig trachea. Eur. J. Pharmac. 231, 97-102.
6. Birdsall N. J. M., Gharagozloo P., Kobayashi S., Kuonen D., Lazareno S., Popham A. and Sugimoto M. (1997) Selective allosteric enhancement of the binding actions of acetylcholine at muscarinic receptor subtypes. Life Sci. 60, 1047-1052.
7. Bonner T. I. (1989) The molecular basis of muscarinic receptor diversity. Trends Neurosci. 12, 143-151.
8. Bonner T. I., Buckley N. J., Young A. C. and Brann M. R. (1987) Identification of a family of muscarinic acetylcholine receptors. Science 237, 527-532.
9. 5 muscarinic acetylcholine receptor genes. Neuron 1, 403-410.
10. Bourgin P., Escourrou P., Gaultier Cl. and Adrien J. (1995) Induction of rapid eye movement sleep by carbachol infusion into the pontine reticular formation in the rat. Neuroreport 6, 532-536.
11. Bourgin P., Lebrand C., Escourrou P., Gaultier Cl., Franc B., Hamon M. and Adrien J. (1997) Vasoactive intestinal polypeptide microinjections into the oral pontine tegmentum enhance rapid eye movement sleep in the rat. Neuroscience 77, 351-360.
12. Buckley N. J., Bonner T. I. and Brann M. R. (1988) Localization of a family of muscarinic receptor mRNAs in rat brain. J. Neurosci. 8, 4646-4652.
13. Caulfield M. P. (1997) Muscarinic receptor classification. In Muscarinic Receptor Subtypes in Smooth Muscles (ed. Eglen R. M.), pp 1-37. CRC, New York.
14. Caulfield M. P. and Birdsall N. J. M. (1998) International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmac. Rev. 50, 279-290.
15. Chedotal A., Cozzari C., Faure M. P., Hartman B. K. and Hamel E. (1994) Distinct choline acetyltransferase (ChAT) and vasoactive intestinal polypeptide (VIP) bipolar neurons project to local blood vessels in the rat cerebral cortex. Brain Res. 646, 181-193.
16. Chowdhury P. S., Guo X., Wakade T. D., Przywara D. A. and Wakade A. R. (1994) Exocytosis from a single rat chromaffin cell by cholinergic and peptidergic neurotransmitters. Neuroscience 59, 1-5.
17. Deurveilher S., Hars B. and Hennevin H. (1997) Pontine microinjection of carbachol does not reliably enhance paradoxical sleep in rats. Sleep 20, 593-607.
18. Dunér-Engström M. and Fredholm B. B. (1993) Breakdown of membrane choline-phospholipids induced by endogenous and exogenous muscarinic agonist is potentiated by VIP in rat submandibular gland. Acta Physiol. Scand. 149, 41-49.
19. Durroux T., Barberis C. and Jard S. (1987) Vasoactive intestinal polypeptide and carbachol act synergistically to induce the hydrolysis of inositol containing phospholipids in the rat superior cervical ganglion. Neurosci. Lett. 75, 211-215.
20. Ebeid A. M., Attia R. R., Sundaram P. and Fischer J. E. (1979) Release of vasoactive intestinal peptide in the central nervous system in man. Am. J. Surg. 137, 123 126.
21. Eckenstein F. and Baughman R. W. (1984) Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide. Nature 309, 153-155.
22. Eglen R. M. and Watson N. (1996) Selective muscarinic receptor agonists and antagonists. Pharmac. Toxic. 78, 59-68.
23. Fukuda K., Kubo T., Akiba I., Maeda A., Mishina M. and Numa S. (1987) Molecular distinction between muscarinic acetylcholine receptor subtypes. Nature 327, 623-625.
24. Goodwin B. P., Anderson G. F. and Barraco R. A. (1995) Characterization of muscarinic receptors in the rat nucleus tractus solitarius. Neurosci. Lett. 191, 131-135.
25. Greene R. W., Gerber U. and McCarley R. W. (1989) Cholinergic activation of medial pontine reticular formation neurons in vitro. Brain Res. 476, 154-159.
26. Hedlund B., Abens J. and Bartfai T. (1983) Vasoactive intestinal polypeptide and muscarinic receptors: Supersensitivity induced by long-term atropine treatment. Science 220, 519-521.
27. Heistad S. D., Marcus M. L., Said S. I. and Gross P. M. (1980) Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow. Am. J. Physiol. 239, H73-H80.
28. 3 muscarinic antagonists on the sleep-wake cycle. NeuroReport 2, 383-385.
29. 3 muscarinic receptors: Specific roles in sleep regulations. Neuroreport 3, 276-278.
30. Iwabuchi Y. and Masuhara T. (1995) Effects of vasoactive intestinal peptide and its homologues on the acetylcholine-mediated secretion of fluid and protein from the rat submandibular gland. Gen. Pharmac. 26, 961-970.
31. Kaji H., Chihara K., Abe H., Kita T., Kashio Y., Okimura Y. and Fujita T. (1985) Effect of passive immunization with antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine amide on 5-hydroxy-L-tryptophan-induced prolactin release in rats. Endocrinology 117, 1914-1919.
32. Kawatani M., Rutigliano M. and De Groat W. C. (1985) Depolarization and muscarinic excitation induced in a sympathetic ganglion by vasoactive intestinal polypeptide. Science 229, 879-881.
33. Kubo T., Fukuda K., Mikami A., Takahashi H., Mishina M., Haga T., Ichiyama A., Kangawa K., Kojima M., Matsuo M., Hirose T. and Numa S. (1986) Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature 323, 560-561.
34. Kubo T., Maeda A., Sugimoto K., Akiba I., Mikami A., Takahashi H., Haga T., Haga K., Ichiyama A., Kangawa K., Matsuo H., Hirose T. N. D. and Numa S. (1986) Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. Fedn Eur. Biochem. Socs Lett. 209, 367-372.
35. Kushida C. A., Zoltoski R. K. and Gillin J. C. (1995) The expression of m1-m3 muscarinic receptor mRNAs in rat brain following REM sleep deprivation. Neuroreport 6, 1705-1708.
36. Lamour Y., Dutar P. and Jobert A. (1983) Effects of neuropeptides on rat cortical neurons: Laminar distribution and interaction with the effect of acetylcholine. Neuroscience 10, 107-117.
37. Lapchak P. A. and Beaudet A. (1990) Cholinergic regulation of vasoactive intestinal peptide content and release in rat frontal cortex and hippocampus. J. Neurochem. 55, 1340-1345.
38. Lapchak P. A. and Collier B. (1988) Vasoactive intestinal peptide increases acetylcholine synthesis by rat hippocampal slices. J. Neurochem. 50, 58-64.
39. 35S]-GTP gamma binding mediated by human muscarinic m1-m4 receptors: Antagonist studies. Br. J. Pharmac. 109, 1120-1127.
40. Lazareno S. and Birdsall N. J. M. (1995) Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Molec. Pharmac. 48, 362-378.
41. Lee N. H. and El-Fakahany E. E. (1991) Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem. Pharmac. 42, 199-205.
42. Leppik R. A., Miller R. C., Eck M. and Paquet J.-L. (1993) Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Molec. Pharmac. 45, 983-990.
43. Luine V. N., Rostene W., Rhodes J. and McEwen B. S. (1984) Activation of choline acetyltransferase by vasoactive intestinal peptide. J. Neurochem. 42, 1131-1134.
44. Lundberg J. M., Hedlund B. and Bartfai T. (1982) Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland. Nature 295, 147-149.
45. Lundberg J. M., Hökfelt T., Schultzberg M., Uvnäs-Wallensten K., Köhler C. and Said S. I. (1979) Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: Evidence from combined immunohistochemistry and acetylcholinesterase staining. Neuroscience 4, 1539-1559.
46. Lydic R. and Baghdoyan H. A. (1994) The neurobiology of rapid eye movement sleep. In Sleep and Breathing (eds Saunders N. A. and Sullivan C. E.), pp. 47-77. Marcel Dekker, New York.
47. 2 muscarinic receptors in the rat brain. Neuroscience 19, 551-564.
48. Masuo Y., Matsumoto Y., Tokito F., Tsuda M. and Fujino M. (1993) Effect of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis. Brain Res. 611, 207-215.
49. Morales M. A., Holmberg K., Xu Z. Q., Cozzari C., Hartman B. K., Emson P., Goldstein M., Elfvin L. G. and Hokfelt T. (1995) Localization of choline acetyltransferase in rat peripheral sympathetic neurons and its coexistence with nitric oxide synthase and neuropeptides. Proc. Natn. Acad. Sci. U.S.A. 92, 11,819-11,823.
50. Murphy P. C., Grieve K. L. and Sillito A. M. (1993) Effects of vasoactive intestinal polypeptide on the response properties of cells in area 17 of the cat visual cortex. J. Neurophysiol. 69, 1465-1474.
51. 2 subtype). Eur. J. Biochem. 220, 29-36.
52. Nishino S., Reid M. S., Dement W. C. and Mignot E. (1994) Neuropharmacology and neurochemistry of canine narcolepsy. Sleep 17, S84-S92.
53. Nunes G. P. Jr, Tufik S. and Nobrega J. N. (1994) Decreased muscarinic receptor binding in rat brain after paradoxical sleep deprivation: An autoradiographic study. Brain Res. 645, 247-252.
54. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
55. Pedigo N. W. and Rice M. A. (1992) Neuropeptide modulation of muscarinic receptors and function in cerebral cortex of young and senescent rats. Eur. J. Pharmac. 225, 151-159.
56. Peralta E. G., Ashkenasi A., Winslow J. W., Ramachandran J. and Capon D. J. (1988) Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature 334, 434-437.
57. 2 muscarinic receptor. Science 238, 672-675.
58. Peters A. and Harriman K. M. (1988) Enigmatic bipolar cell of rat visual cortex. J. Comp. Neurol. 267, 409-432.
59. Pompeiano M. and Tonioni G. (1990) Changes in pontine muscarinic receptor binding during sleep-waking states in the rat. Neurosci. Lett. 109, 347-352.
60. 2-like receptor sub-type. Neuroscience 29, 271-289.
61. 5/m5 receptor subtype: Fact or fiction. Life Sci. 60, 1105-1112.
62. 2 muscarinic receptors. Sleep 17, 424-435.
63. Rouse S. T., Thomas T. M. and Levey A. I. (1997) Muscarinic acetylcholine receptor subtype, m2: Diverse functional implications of differential synaptic localization. Life Sci. 60, 1031-1038.
64. 3 muscarinic receptors in paradoxical sleep generation in the cat. Eur. J. Neurosci. 9, 415-423.
65. Shuman S. L., Capece M. I., Baghdoyan H. A. and Lydic R. (1995) Pertussis toxin-sensitive proteins mediate carbachol-induced REM sleep and respiratory depression. Am. J. Physiol. 269, R308-R317.
66. 1A agonist, on sleep/wakefulness cycles: Probable post-synaptic action. J. Sleep Res. 2, 103-109.
67. Tobin G., Ekström J., Ekman R. and Håkanson R. (1994) Influence of atropine on the depletion of vasoactive intestinal peptide, substance P and calcitonin gene-related peptide from rat parotid gland in response to parasympathetic nerve stimulation. Acta Physiol. Scand. 150, 463-465.
68. 2 muscarinic receptor agonists on REM sleep generation. Brain Res. 503, 128-131.
69. Velasquez-Moctezuma J., Shalauta M. D., Gillin J. C. and Shiromani P. J. (1990) Differential effects of cholinergic antagonists on REM sleep components. Psychopharmac. Bull. 26, 349-353.
70. Velasquez-Moctezuma J., Shalauta M. D., Gillin J. C. and Shiromani P. J. (1991) Cholinergic antagonists and REM sleep generation. Brain Res. 543, 175-179.
71. Vertes R. P. (1977) Selective firing of rat pontine gigantocellular neurons during movement and REM sleep. Brain Res. 128, 146-152.
72. Vilaro M. T., Wiederhold K.-H., Palacios J. M. and Mengod G. (1992) Muscarinic m2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: A correlative study using in situ hybridization histochemistry and receptor autoradiography. Neuroscience 47, 367-393.
73. Wang J. Y., Yaksh T. L., Harty G. J. and Go V. L. W. (1986) Neurotransmitter modulation of VIP release from cat cerebral cortex. Am. J. Physiol. 250, R104-R111.
74. Wei J., Walton E. A., Milici A. and Buccafusco J. J. (1994) M1-m5 muscarinic receptors distribution in rat CNS by RT-PCR and HPLC. J. Neurochem. 63, 815-821.
75. Whittaker V. P. (1989) Vasoactive intestinal polypeptide (VIP) as cholinergic co-transmitter: Some recent results. Cell Biol. Int. Rep. 13, 1039-1051.